$RGEN
REPLIGEN CORP Stock $rgen

$rgen Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-Q Financial Statement

#000119312518315604 Filed on November 01, 2018

Income Statement

Concept	2018 Q4	2018 Q3	2017 Q3
Revenue	$51.94M	$49.53M	$36.58M
YoY Change	24.83%	35.4%	48.24%
Cost Of Revenue	$23.60M	$22.18M	$19.99M
YoY Change	23.33%	10.99%	77.79%
Gross Profit	$28.35M	$27.35M	$16.59M
YoY Change	26.14%	64.8%	23.51%
Gross Profit Margin	54.58%	55.21%	45.36%
Selling, General & Admin	$14.70M	$15.86M	$15.00M
YoY Change	-8.94%	5.74%	110.44%
% of Gross Profit	51.85%	57.99%	90.39%
Research & Development	$3.200M	$3.601M	$2.001M
YoY Change	4.27%	79.96%	6.1%
% of Gross Profit	11.29%	13.17%	12.06%
Depreciation & Amortization	$4.000M	$3.890M	$3.090M
YoY Change	-3.38%	25.89%	125.55%
% of Gross Profit	14.11%	14.23%	18.62%
Operating Expenses	$44.09M	$41.64M	$36.99M
YoY Change	14.97%	12.59%	310.36%
Operating Profit	-$15.74M	$7.886M	-$406.0K
YoY Change	-582.5%	-2042.36%	-110.84%
Interest Expense	-$1.100M	$1.687M	$1.618M
YoY Change	-167.2%	4.26%	4.05%
% of Operating Profit		21.39%
Other Income/Expense, Net	$100.0K	-$1.263M	-$1.616M
YoY Change	-171.94%	-21.84%	2054.67%
Pretax Income	$6.900M	$6.623M	-$2.022M
YoY Change	345.45%	-427.55%	-191.33%
Income Tax	$1.200M	$1.829M	-$6.691M
% Of Pretax Income	17.39%	27.62%
Net Earnings	$5.638M	$4.794M	$4.669M
YoY Change	-53.7%	2.68%	304.24%
Net Earnings / Revenue	10.85%	9.68%	12.76%
Basic Earnings Per Share	$0.13	$0.11	$0.11
Diluted Earnings Per Share	$0.12	$0.10	$0.11
COMMON SHARES
Basic Shares Outstanding	43.86M shares	43.82M shares	41.24M shares
Diluted Shares Outstanding		45.83M shares	42.56M shares

Balance Sheet

Concept	2018 Q4	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$193.8M	$190.3M	$159.7M
YoY Change	11.51%	19.16%	-10.63%
Cash & Equivalents	$193.8M	$190.3M	$159.7M
Short-Term Investments			$0.00
Other Short-Term Assets	$697.0K	$3.800M	$2.800M
YoY Change	219.72%	35.71%	115.38%
Inventory	$42.26M	$42.28M	$38.66M
Prepaid Expenses
Receivables	$33.02M	$30.78M	$29.48M
Other Receivables	$2.800M	$0.00	$600.0K
Total Short-Term Assets	$275.7M	$267.2M	$231.2M
YoY Change	13.57%	15.59%	5.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$32.18M	$29.36M	$22.06M
YoY Change	43.55%	33.11%	47.68%
Goodwill	$326.7M	$327.0M	$326.7M
YoY Change	-0.18%	0.1%	948.27%
Intangibles	$135.4M	$136.5M	$147.4M
YoY Change	-6.44%	-7.38%	689.55%
Long-Term Investments
YoY Change
Other Assets	$174.0K	$2.007M	$6.467M
YoY Change	-97.21%	-68.97%	1193.4%
Total Long-Term Assets	$498.9M	$494.9M	$503.0M
YoY Change	-0.37%	-1.62%	671.33%
TOTAL ASSETS
Total Short-Term Assets	$275.7M	$267.2M	$231.2M
Total Long-Term Assets	$498.9M	$494.9M	$503.0M
Total Assets	$774.6M	$762.1M	$734.2M
YoY Change	4.18%	3.8%	157.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.49M	$9.482M	$6.423M
YoY Change	44.04%	47.63%	26.91%
Accrued Expenses	$15.87M	$17.96M	$13.79M
YoY Change	-11.51%	30.24%	-8.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$103.5M	$102.4M	$98.20M
YoY Change		4.28%
Total Short-Term Liabilities	$129.8M	$129.8M	$118.4M
YoY Change	415.02%	9.62%	486.6%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Other Long-Term Liabilities	$4.125M	$4.672M	$1.573M
YoY Change	76.06%	197.01%	-16.95%
Total Long-Term Liabilities	$4.125M	$4.672M	$1.573M
YoY Change	76.06%	197.01%	-16.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$129.8M	$129.8M	$118.4M
Total Long-Term Liabilities	$4.125M	$4.672M	$1.573M
Total Liabilities	$159.1M	$134.5M	$120.0M
YoY Change	4.66%	12.08%	443.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$15.57M	-$21.21M	-$43.69M
YoY Change	-50.59%	-51.46%	-32.68%
Common Stock	$643.0M	$639.5M	$627.2M
YoY Change	2.16%	1.96%	160.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$615.6M	$606.5M	$576.9M
YoY Change
Total Liabilities & Shareholders Equity	$774.6M	$762.1M	$734.2M
YoY Change	4.18%	3.8%	157.58%

Cashflow Statement

Concept	2018 Q4	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$5.638M	$4.794M	$4.669M
YoY Change	-53.7%	2.68%	304.24%
Depreciation, Depletion And Amortization	$4.000M	$3.890M	$3.090M
YoY Change	-3.38%	25.89%	125.55%
Cash From Operating Activities	$5.550M	$19.68M	-$1.730M
YoY Change	-63.53%	-1237.57%	46.61%
INVESTING ACTIVITIES
Capital Expenditures	-$4.200M	-$4.170M	-$1.010M
YoY Change	138.64%	312.87%	-50.73%
Acquisitions
YoY Change
Other Investing Activities	-$1.260M	$0.00	-$110.2M
YoY Change	-940.0%	-100.0%	829.96%
Cash From Investing Activities	-$5.460M	-$4.170M	-$111.2M
YoY Change	237.04%	-96.25%	700.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$129.3M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.050M	880.0K	129.8M
YoY Change	238.71%	-99.32%	30807.14%
NET CHANGE
Cash From Operating Activities	5.550M	19.68M	-1.730M
Cash From Investing Activities	-5.460M	-4.170M	-111.2M
Cash From Financing Activities	1.050M	880.0K	129.8M
Net Change In Cash	1.140M	16.39M	16.87M
YoY Change	-91.8%	-2.85%	-215.08%
FREE CASH FLOW
Cash From Operating Activities	$5.550M	$19.68M	-$1.730M
Capital Expenditures	-$4.200M	-$4.170M	-$1.010M
Free Cash Flow	$9.750M	$23.85M	-$720.0K
YoY Change	-42.58%	-3412.5%	-182.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	159666000
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	9482000
CY2018Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	261000
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11773000
CY2018Q3	us-gaap	Assets Assets	762125000
CY2018Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2719000
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	164000
CY2018Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17964000
CY2018Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1065000
CY2018Q3	us-gaap	Assets Current AssetsCurrent	267248000
CY2018Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1728000
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30784000
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	563000
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27015000
CY2018Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	639027000
CY2018Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	764000
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	190304000
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190304000
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43853389	shares
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	960000
CY2018Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43853389	shares
CY2018Q3	us-gaap	Common Stock Value CommonStockValue	439000
CY2018Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	10086000
CY2018Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	102400000
CY2018Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	21120000
CY2018Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1234000
CY2018Q3	us-gaap	Deferred Revenue DeferredRevenue	1234000
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	28360000
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7986000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20879000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9363000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9361000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9854000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	10433000
CY2018Q3	us-gaap	Goodwill Goodwill	326977000
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	136534000
CY2018Q3	us-gaap	Inventory Net InventoryNet	42284000
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2636000
CY2018Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	5156000
CY2018Q3	us-gaap	Land Land	1023000
CY2018Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	157413000
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11657000
CY2018Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	24349000
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6278000
CY2018Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	15940000
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	762125000
CY2018Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	129846000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2957000
CY2018Q3	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	0
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	3266000
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2007000
CY2018Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	23405000
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1803000
CY2018Q3	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	0
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4672000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	3425000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2049000
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	893000
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3830000
CY2018Q3	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	46000
CY2018Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	605000
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1033312	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.99
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	606487000
CY2018Q3	rgen	Operating Lease Future Minimum Payments Due In Four Years And Thereafter OperatingLeaseFutureMinimumPaymentsDueInFourYearsAndThereafter	4872000
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29359000
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2906351	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	28429000
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	986509	shares
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21206000
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	56374000
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	16325000
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	26.64
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	29421000
CY2018Q3	us-gaap	Share Price SharePrice	55.46
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	444446	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.73
CY2018Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43859319	shares
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	122233000
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7282000
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1191000
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6363000
CY2017Q4	us-gaap	Assets Assets	743519000
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1668000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	58000
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17929000
CY2017Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1383000
CY2017Q4	us-gaap	Assets Current AssetsCurrent	242782000
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27585000
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	947000
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23800000
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	628983000
CY2017Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	764000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	173759000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	173759000
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43587079	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43587079	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	436000
CY2017Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2581000
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	441000
CY2017Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	99250000
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	25167000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13062000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6374000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.838	pure
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9560000
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13331000
CY2017Q4	us-gaap	Goodwill Goodwill	327333000
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	144753000
CY2017Q4	us-gaap	Inventory Net InventoryNet	39004000
CY2017Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	4272000
CY2017Q4	us-gaap	Land Land	1023000
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	158084000
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12570000
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	21678000
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4756000
CY2017Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	15673000
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	743519000
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25211000
CY2017Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	0
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6234000
CY2017Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	21904000
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1622000
CY2017Q4	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	0
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2343000
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2281000
CY2017Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	153000
CY2017Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	598000
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22417000
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31508000
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	46217000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	734940	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.80
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	591548000
CY2018Q2	rgen	Lease Agreement Area LeaseAgreementArea	40000	sqft
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3476000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2958000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	326572	shares
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	37433000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23277000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	47913000
	us-gaap	Costs And Expenses CostsAndExpenses	88881000
	us-gaap	Depreciation Depreciation	2988000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2633000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3555000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-171000
	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-64000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	704000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5699000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10476000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	159000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-196000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	739000
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	496402	shares
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8472000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6089000
	us-gaap	Interest Expense InterestExpense	4804000
	us-gaap	Investment Income Net InvestmentIncomeNet	308000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-699000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	454340	shares
	us-gaap	Interest Paid Net InterestPaidNet	1222000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-97075000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7097000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	129642000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5044000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2233000
	us-gaap	Net Income Loss NetIncomeLoss	16175000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-548000
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	112941000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3686000
	us-gaap	Operating Income Loss OperatingIncomeLoss	10743000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	5000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	19600000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2035000
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	1702000
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	48000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	129309000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35365000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.94
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	99624000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5603000
	us-gaap	Share Based Compensation ShareBasedCompensation	4845000
	us-gaap	Stock Issued1 StockIssued1	247575000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2074000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37386333	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36435591	shares
	rgen	Payment Of Contingent Consideration In Common Stock PaymentOfContingentConsiderationInCommonStock	1062000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7906000
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3160000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	485520	shares
	us-gaap	Basis Of Accounting BasisOfAccounting	<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="PAGE-BREAK-INSIDE: avoid"> <td valign="top" width="4%" align="left"><b>1.</b></td> <td valign="top" align="left"> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="left"><b>Basis of Presentation</b></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"> The condensed consolidated financial statements included herein have been prepared by Repligen Corporation (the “Company”, “Repligen” or “we”) in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for Quarterly Reports on Form <font style="WHITE-SPACE: nowrap">10-Q</font> and Article 10 of Regulation <font style="WHITE-SPACE: nowrap">S-X</font> and do not include all of the information and footnote disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on Form <font style="WHITE-SPACE: nowrap">10-K</font> for the fiscal year ended December 31, 2017.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Repligen Sweden AB (“Repligen Sweden”), Repligen GmbH, Repligen Singapore Pte. Ltd., our former subsidiary, TangenX Technology Corporation (“TangenX,” which was acquired on December 14, 2016 and merged into the Company as of June 30, 2017) and Spectrum LifeSciences, LLC (“Spectrum,” which was acquired on August 1, 2017). All significant intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"> <b><i>Recent Accounting Standards Updates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"> We consider the applicability and impact of all Accounting Standards Updates on our condensed consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated financial position or results of operations. Recently issued Accounting Standards Updates which we feel may be applicable to us are as follows:</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"> <i>Recently Issued Accounting Standard Updates – Not Yet Adopted</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"> In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. (“ASU”) <font style="WHITE-SPACE: nowrap">2016-02,</font><i> “Leases (Topic 842).”</i> Subsequently, the FASB issued additional updates which clarify this guidance, including ASU <font style="WHITE-SPACE: nowrap">2018-01,</font> <i>“Leases (Topic 842): Land Easement Practical Expedient for Transitioning to Topic 842,”</i> in January 2018, which allows an entity to elect an optional transition practical expedient to not evaluate land easements that exist or expired before the entity’s adoption of Topic 842, and ASU <font style="WHITE-SPACE: nowrap">2018-11,</font> <i>“Leases – Targeted Improvements (Topic 842),”</i> in July 2018, that gives entities the option to not provide comparative period financial statements and instead apply the transition requirements as of the effective date of the new standard. The Company plans to adopt the new standard using this optional method. Pursuant to the guidance under ASU <font style="WHITE-SPACE: nowrap">2016-02,</font> the Company also plans to elect the optional package of practical expedients, which will allow the Company to not reassess: (i) whether expired or existing contracts contain leases; (ii) lease classification for any expired or existing leases; and (iii) initial direct costs for any existing leases. The new standard also allows entities to make certain policy elections, some of which the Company also plans to elect, including: a policy to not record short-term leases on the balance sheet. The Company is currently working through lease contract scoping, design and implementation of transition related controls, and finalization of accounting elections. The Company is still assessing the impact this standard will have on its consolidated financial statements and disclosures; however, it anticipates that the new standard will result in the Company recording additional right of use assets and corresponding liabilities on its consolidated balance sheet.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In February 2018, the FASB issued ASU <font style="WHITE-SPACE: nowrap">2018-02,</font> <i>“Income Statement – Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income,”</i> which gives entities the option to reclassify to retained earnings tax effects related to items that have been stranded in accumulated other comprehensive income as a result of the Tax Cuts and Jobs Act (the “Act”). For all entities, the guidance is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Entities can choose whether to apply the amendments retrospectively to each period in which the effect of the Act is recognized or to apply the amendments in the period of adoption. The Company has not assessed the impact of the new standard on its consolidated financial statements but does not expect its adoption to have a material impact on the Company’s consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In August 2018, the FASB issued ASU 2018-13, <i>“Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.”</i> ASU 2018-13 includes amendments that aim to improve the effectiveness of fair value measurement disclosures. The amendments in this guidance modify the disclosure requirements on fair value measurements based on the concepts in FASB Concepts Statement, <i>“</i><i>Conceptual Framework for Financial Reporting – Chapter 8: Notes to Financial Statements</i>,<i>”</i> including the consideration of costs and benefits. The amendments become effective for the Company in the year ending December 31, 2020 and early adoption is permitted. The Company is currently assessing the impact that this guidance will have on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In August 2018, the FASB issued ASU 2018-15, <i>“Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.”</i> ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance also requires the entity to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement, which includes reasonably certain renewals. The guidance becomes effective for the Company in the year ending December 31, 2020 and early adoption is permitted. The Company is currently assessing the impact that this guidance will have on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"> <i>Recently Issued Accounting Standard Updates – Adopted During the Period</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 6pt"> In May 2014, the FASB issued <font style="WHITE-SPACE: nowrap">ASU 2014-09,</font> <i>“Revenue from Contracts with Customers (Topic 606),”</i> (“ASC 606”) which supersedes the revenue recognition requirements in Accounting Standards Codification (“ASC”) Topic 605, <i>“Revenue Recognition</i>,<i>”</i> and creates a new Topic 606, <i>“Revenue from Contracts with Customers</i>.<i>”</i> Two adoption methods are permitted: retrospectively to all prior reporting periods presented, with certain practical expedients permitted; or retrospectively with the cumulative effect of initially adopting the ASU recognized at the date of initial application. The adoption of this ASU included updates as provided under ASU <font style="WHITE-SPACE: nowrap">2015-14,</font> <i>“Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date”</i>; ASU <font style="WHITE-SPACE: nowrap">2016-08,</font> <i>“Revenue from Contracts with Customers (Topic</i><i> 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)”</i>; ASU <font style="WHITE-SPACE: nowrap">2016-10,</font> <i>“Revenue from Contracts with Customers (Topic</i><i> 606): Identifying Performance Obligations and Licensing”</i>; and ASU <font style="WHITE-SPACE: nowrap">2016-12,</font> <i>“Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.”</i> The Company adopted the provisions of ASC 606 using the modified retrospective method effective January 1, 2018. See Note 3 for further discussion of the effects of this standard on the Company’s consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In August 2016, the FASB issued ASU <font style="WHITE-SPACE: nowrap">2016-15,</font> <i>“Statement of Cash Flows (Topic 203): Classification of Certain Cash Receipts and Cash Payments.”</i> ASU <font style="WHITE-SPACE: nowrap">2016-15</font> addresses eight specific cash flow issues and clarifies their presentation and classification in the Statement of Cash Flows. ASU <font style="WHITE-SPACE: nowrap">2016-15</font> is effective for fiscal years beginning after December 15, 2017 and is to be applied retrospectively with early adoption permitted. The Company has historically classified payments up to the amount of its contingent consideration liability recognized at the date of its acquisition as financing activities, with additional payments classified as operating activities. Because the Company has classified its contingent consideration payments as required by this standard, the adoption of this standard did not have any impact on its consolidated financial statements when applied on a retrospective basis.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In October 2016, the FASB issued ASU <font style="WHITE-SPACE: nowrap">2016-16,</font><i> “Intra-Entity Transfers of Assets Other Than Inventory.”</i> ASU <font style="WHITE-SPACE: nowrap">2016-16</font> requires that the income tax consequences of an intra-entity asset transfer other than inventory are recognized at the time of the transfer. An entity will continue to recognize the income tax consequences of an intercompany transfer of inventory when the inventory is sold to a third party. The Company adopted this standard on a modified-retrospective basis on January 1, 2018. See Note 12 for a discussion of the impact of this ASU on the Company’s consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In November 2016, the FASB issued ASU <font style="WHITE-SPACE: nowrap">2016-18,</font> <i>“Statement of Cash Flows (Topic 230): Restricted Cash,”</i> which requires that the statement of cash flows explain the change during the period in the total cash, which is inclusive of cash and cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. Restricted cash and restricted cash equivalents will be included with cash and cash equivalents when reconciling the beginning of period and end of period balances on the statement of cash flows upon adoption of this standard. The Company adopted this standard on a retrospective basis on January 1, 2018. The adoption resulted in an increase to cash, cash equivalents and restricted cash of $450,000 in the statement of cash flows at December 31, 2016 and September 30, 2017. The Company did not hold any restricted cash at December 31, 2017 or September 30, 2018.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In January 2017, the FASB issued <font style="WHITE-SPACE: nowrap">ASU 2017-01,</font><i> “Business Combinations (Topic 805): Clarifying the Definition of a Business”</i>, which clarifies the definition of a business to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The Company adopted this standard as of January 1, 2018, and the adoption of ASU <font style="WHITE-SPACE: nowrap">2017-01</font> did not have a material impact on the Company’s consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 12pt"> In January 2017, the FASB issued ASU <font style="WHITE-SPACE: nowrap">2017-04,</font> <i>“Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,”</i> eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. ASU <font style="WHITE-SPACE: nowrap">2017-04</font> requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. The Company adopted this standard as of January 1, 2018, and the adoption of this standard did not have a material impact on the Company’s consolidated financial statements.</p> </div>
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	16545000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5569000
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	62939000
	us-gaap	Costs And Expenses CostsAndExpenses	123955000
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	472000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11775000
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.246	pure
	us-gaap	Depreciation Depreciation	3871000
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Type DocumentType	10-Q
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P4Y6M3D
	dei	Entity Registrant Name EntityRegistrantName	REPLIGEN CORP
	dei	Entity Small Business EntitySmallBusiness	false
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4453000
	dei	Entity Central Index Key EntityCentralIndexKey	0000730272
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3120000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	87000
	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P16Y
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1348000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	14565000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3586000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3354000
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	149000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1437000
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	892179	shares
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1583000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1070000
	us-gaap	Interest Expense InterestExpense	5008000
	us-gaap	Investment Income Net InvestmentIncomeNet	1251000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4805000
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	511433	shares
	us-gaap	Interest Paid Net InterestPaidNet	1222000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8580000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5410000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2363000
	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	5609000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3570000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27215000
	us-gaap	Net Income Loss NetIncomeLoss	10979000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	187000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8580000
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Operating Income Loss OperatingIncomeLoss	18135000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2374000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48347000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y3M14D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.56
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	11000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	142090000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	107000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12669000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	34.79
	us-gaap	Share Based Compensation ShareBasedCompensation	7672000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	9588	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M17D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	18.02
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	29.71
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	439678	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y3M14D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2113000
CY2017	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	Expire at various dates through December 2037.
CY2017	us-gaap	Tax Credit Carryforward Limitations On Use TaxCreditCarryforwardLimitationsOnUse	Expire at various dates through December 2037.
CY2017	rgen	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit	12812000
CY2017	rgen	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense	3266000
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	162544	shares
	dei	Trading Symbol TradingSymbol	RGEN
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	131718	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45132115	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43728503	shares
	rgen	Increase Decrease In Revenues IncreaseDecreaseInRevenues	42466000
	rgen	Increase Decrease In Royalty Revenue IncreaseDecreaseInRoyaltyRevenue	-60000
	rgen	Increase Decrease In Sales Revenue Goods Net IncreaseDecreaseInSalesRevenueGoodsNet	42526000
	rgen	Gain Loss On Conversion Of Debt GainLossOnConversionOfDebt	-1000
	rgen	Lease Agreement Payment Condition LeaseAgreementPaymentCondition	Fixed rent with respect to 40,000 square feet of the Premises commenced on the Commencement Date, and rent for the full 63,761 square feet of the Premises shall begin 19 months following the Commencement Date.
	rgen	Option To Extend Lease Years OptionToExtendLeaseYears	2	pure
	rgen	Percentage Change In Revenue PercentageChangeInRevenue	0.426	pure
	rgen	Percentage Change In Royalty Revenue PercentageChangeInRoyaltyRevenue	-0.556	pure
	rgen	Percentage Change In Sales Revenue Goods Net PercentageChangeInSalesRevenueGoodsNet	0.427	pure
	rgen	Impairment Loss On Receivables ImpairmentLossOnReceivables	0
	rgen	Property Plant And Equipment Related To Lease Incentives PropertyPlantAndEquipmentRelatedToLeaseIncentives	2270000
CY2018Q1	rgen	Lease Commencement Date LeaseCommencementDate	2018-06-01
CY2018Q1	rgen	Lease Agreement Term LeaseAgreementTerm	P126M
CY2018Q1	rgen	Lease Agreement Area LeaseAgreementArea	63761	sqft
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2017	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P16Y
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6694000
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	19987000
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	36986000
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	3.309	pure
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2022000
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6691000
CY2017Q3	us-gaap	Income Tax Reconciliation Disposition Of Assets IncomeTaxReconciliationDispositionOfAssets	-5625000
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	842206	shares
CY2017Q3	us-gaap	Interest Expense InterestExpense	1618000
CY2017Q3	us-gaap	Investment Income Net InvestmentIncomeNet	102000
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	484242	shares
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2025000
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1616000
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	4669000
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-406000
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14998000
CY2017Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	36580000
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2001000
CY2017Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1817000
CY2017Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-9200000
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42563002	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41236554	shares
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	329409	shares
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4164000
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	22183000
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	41643000
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.276	pure
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
CY2018Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights	0	shares
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6623000
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1829000
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1354438	shares
CY2018Q3	us-gaap	Interest Expense InterestExpense	1687000
CY2018Q3	us-gaap	Investment Income Net InvestmentIncomeNet	558000
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	651265	shares
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-630000
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1263000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	4794000
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-134000
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	7886000
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15859000
CY2018Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	49529000
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3601000
CY2018Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2779000
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45828175	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43822472	shares
CY2018Q3	rgen	Increase Decrease In Revenues IncreaseDecreaseInRevenues	12949000
CY2018Q3	rgen	Increase Decrease In Royalty Revenue IncreaseDecreaseInRoyaltyRevenue	-37000
CY2018Q3	rgen	Increase Decrease In Sales Revenue Goods Net IncreaseDecreaseInSalesRevenueGoodsNet	12986000
CY2018Q3	rgen	Percentage Change In Revenue PercentageChangeInRevenue	0.354	pure
CY2018Q3	rgen	Percentage Change In Royalty Revenue PercentageChangeInRoyaltyRevenue	-0.561	pure
CY2018Q3	rgen	Percentage Change In Sales Revenue Goods Net PercentageChangeInSalesRevenueGoodsNet	0.356	pure
CY2018Q3	rgen	Impairment Loss On Receivables ImpairmentLossOnReceivables	0

Files In Submission

Name	View Source	Status
0001193125-18-315604-index-headers.html	Edgar Link	pending
0001193125-18-315604-index.html	Edgar Link	pending
0001193125-18-315604.txt	Edgar Link	pending
0001193125-18-315604-xbrl.zip	Edgar Link	pending
d635607d10q.htm	Edgar Link	pending
d635607dex311.htm	Edgar Link	pending
d635607dex312.htm	Edgar Link	pending
d635607dex321.htm	Edgar Link	pending
d635607dex41.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rgen-20180930.xml	Edgar Link	completed
rgen-20180930.xsd	Edgar Link	pending
rgen-20180930_cal.xml	Edgar Link	unprocessable
rgen-20180930_def.xml	Edgar Link	unprocessable
rgen-20180930_lab.xml	Edgar Link	unprocessable
rgen-20180930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RGEN
REPLIGEN CORP Stock $rgen

2018 Q4 Form 10-Q Financial Statement

#000119312518315604 Filed on November 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGEN REPLIGEN CORP Stock $rgen

2018 Q4 Form 10-Q Financial Statement

#000119312518315604 Filed on November 01, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGEN
REPLIGEN CORP Stock $rgen